BridgeBio Pharma, Inc. (BBIO) Financials
BBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 849.3 million | 1.9 billion |
| 2023-12-31 | 546.4 million | 1.9 billion |
| 2023-09-30 | 655.0 million | 1.8 billion |
| 2023-06-30 | 503.7 million | 1.9 billion |
BBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -221.0 million | 17.1 million |
| 2023-12-31 | -125.3 million | 37.0 million |
| 2023-09-30 | -145.7 million | 22.6 million |
| 2023-06-30 | -113.8 million | 27.2 million |
BBIO Net Income
No data available :(
BBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 519.8 million | - | 12.8 million |
| 2023-12-31 | 434.9 million | - | 13.1 million |
| 2023-09-30 | 505.2 million | - | 13.9 million |
| 2023-06-30 | 333.3 million | - | 14.7 million |
BBIO Shares Outstanding
BBIO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 1.5 million | 141.0 million | 65.8 million | - |
| 2023-12-31 | 435000 | 130.2 million | 47.6 million | - |
| 2023-09-30 | 431000 | 125.1 million | 35.8 million | - |
| 2023-06-30 | 428000 | 108.1 million | 36.1 million | - |
BBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 211.1 million | 1.9 million |
| 2023-12-31 | 1.7 million | 598000 |
| 2023-09-30 | 4.1 million | 598000 |
| 2023-06-30 | 1.6 million | 599000 |
BBIO
Price: $29.73
52 week price:
Earnings Per Share: -3.23 USD
P/E Ratio: -8.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Market Capitalization: 5.2 billion